Elicio Therapeutics Expected Short fall
| ELTX Stock | | | 9.91 -0.10 -1.00% |
Expected shortfall (or ES) is a risk measure that evaluates the market risk of an equity instrument. It is an alternative to value at risk that is more sensitive to the shape of the loss distribution in the tail of the distribution. The expected shortfall at a particular level is the expected return on the portfolio in the worst percent of the cases. Expected shortfall is also called conditional value at risk (CVaR), average value at risk (AVaR), and expected tail loss (ETL). Below is Elicio Therapeutics's current Expected Short fall with peer comparisons and related risk metrics.
Current Expected Short fall Value
Elicio Therapeutics registers a Expected Short fall of
-4.82, reflecting its current reading on this measure. This reflects Elicio Therapeutics's positioning relative to its own recent range within Pharmaceuticals.
Expected Shortfall | = | Conditional VAR |
| = | -4.82 | |
Expected Short fall Peers Comparison
The peer group averages -4.36 for Expected Short fall, with Elicio Therapeutics at -4.8195 falling below that level. Readings span -4.8872 (Milestone Pharmaceuticals) to 0.0 ().
Expected Short fall Relative To Other Indicators
The chart below plots Expected Short fall against Maximum Drawdown for Elicio Therapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Expected Short fall while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Compare Elicio Therapeutics to PeersMethodology, Assumptions & Data Sources
Elicio Therapeutics has a current Expected Short fall reading of -4.82. The Expected Short fall for Elicio Therapeutics is produced by transforming raw price history into a standardized measure according to the indicator's defined methodology. The underlying data comes from exchange-reported daily closes with corporate action adjustments applied where relevant. Elicio Therapeutics operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Indicator accuracy depends on data continuity across the calculation period. Gaps in trading history may affect the output.
Other Technical Indicators